Internal Medicine, Rheumatology · Lafayette, LA
NPI
1043260607
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4212 W Congress St Ste 2300a
Lafayette, LA, 70506
Phone (337) 237-7801
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
168,231 services
Medicare patients, 2024
811
Average age 73
Drug cost, 2024
$7.8M
11,054 prescriptions
Company payments, 2025
$244
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James M Lipstate was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 86,000 times for 32 patients. In total James M Lipstate billed 168,231 services in 64 codes, and Medicare paid $1.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 86,000 | 32 | $3.62 | $311K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,325 | 15 | $33.81 | $349K |
| J0897 Injection, denosumab, 1 mg | Office | 9,000 | 84 | $19.93 | $179K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,739 | 97 | $0.10 | $372 |
| 99214 Office E&M - Established | Office | 1,185 | 700 | $81.68 | $97K |
| 36415 Venipuncture Blood Collection | Office | 1,112 | 601 | $8.64 | $9,610 |
| 84550 Clinical Chemistry | Office | 1,033 | 597 | $4.40 | $4,545 |
| 82550 Clinical Chemistry | Office | 1,033 | 594 | $6.34 | $6,551 |
| 82248 Clinical Chemistry | Office | 1,029 | 594 | $4.89 | $5,028 |
| 84100 Clinical Chemistry | Office | 1,029 | 594 | $4.62 | $4,752 |
| 80053 Clinical Chemistry | Office | 1,026 | 594 | $10.28 | $11K |
| 85025 Blood Count | Office | 971 | 561 | $7.56 | $7,342 |
| 85652 Clinical Chemistry | Office | 765 | 480 | $2.63 | $2,013 |
| 86140 Clinical Chemistry | Office | 764 | 478 | $5.05 | $3,858 |
| 96401 Chemotherapy Administration | Office | 557 | 117 | $49.71 | $28K |
By year: 2022 $1.5M for 183,765 services; 2023 $1.5M for 192,904 services; 2024 $1.4M for 168,231 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,112 | 601 | $8.64 | $9,610 |
| 82550 Clinical Chemistry | 1,033 | 594 | $6.34 | $6,551 |
| 84550 Clinical Chemistry | 1,033 | 597 | $4.40 | $4,545 |
| 84100 Clinical Chemistry | 1,029 | 594 | $4.62 | $4,752 |
| 82248 Clinical Chemistry | 1,029 | 594 | $4.89 | $5,028 |
| 80053 Clinical Chemistry | 1,026 | 594 | $10.28 | $11K |
| 85025 Blood Count | 971 | 561 | $7.56 | $7,342 |
| 85652 Clinical Chemistry | 765 | 480 | $2.63 | $2,013 |
| 86140 Clinical Chemistry | 764 | 478 | $5.05 | $3,858 |
| 81003 Clinical Chemistry | 47 | 41 | $2.16 | $102 |
Medicare prescription drug claims, 2024
In 2024, the drug James M Lipstate prescribed most often to Medicare patients was Prednisone, with 1,421 prescriptions and refills. In total James M Lipstate wrote 11,054 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,421 | 1,964 | 280 | $5,395 |
| Methotrexate Methotrexate Sodium | 1,169 | 1,580 | 239 | $18K |
| Hydroxychloroquine Sulfate Generic | 889 | 1,226 | 167 | $23K |
| Tramadol Hcl Generic | 869 | 869 | 163 | $7,211 |
| Celecoxib Generic | 552 | 742 | 120 | $15K |
| Gabapentin Generic | 508 | 616 | 89 | $4,592 |
| Allopurinol Generic | 345 | 643 | 76 | $2,871 |
| Humira(Cf) Pen Adalimumab | 281 | 290 | 37 | $2.0M |
| Pregabalin Generic | 276 | 365 | 48 | $4,142 |
| Alendronate Sodium Generic | 276 | 449 | 64 | $1,509 |
| Meloxicam Generic | 265 | 385 | 65 | $1,032 |
| Sulfasalazine Generic | 265 | 406 | 59 | $5,292 |
| Duloxetine Hcl Generic | 264 | 439 | 43 | $3,018 |
| Leflunomide Generic | 223 | 294 | 47 | $7,018 |
| Diclofenac Sodium Generic | 211 | 296 | 48 | $3,023 |
Brand drugs: - claims; generic drugs: 9,393 claims; opioid claims: 1,057.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James M Lipstate $244 ($244 in general payments such as food, travel and fees) from 4 companies. The largest payer was GlaxoSmithKline, LLC. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.